Você procurou por: sesiasdesimt (Lituano - Inglês)

c/sesiasdesimt
c / sixty

sesiasdesimt du asmenys buvo gydyti bent metus.
sixty-two subjects had at least one year of treatment.

sesiasdesimt septyniems procentams pacient pavyko titruoti veiksmingj vaisto doz.
sixty-seven percent of the patients were able to be titrated to an effective dose.

bent vien su infuzija susijusi reakcij patyr sesiasdesimt septyni procentai (67%) pacient.
sixty seven percent (67%) of the patients experienced at least one infusion-associated reaction.

sesiasdesimt septyni procentai pacient sirgo storosios zarnos vziu ir 33% -tiesiosios zarnos vziu.
sixty-seven percent of patients had colon cancer and 33% had rectal cancer.

sesiasdesimt vienas pacientas uzbaig tyrim (per vis tyrimo laikotarp 35 pacientai gavo rekomenduojam 400/100 mg doz du kartus per par) .
sixty-one patients completed the study (35 patients received the recommended 400/100 mg twice daily dose throughout the study) .

55 pro30017 tyrimo a pogrupyje dalyvavo simtas sesiasdesimt trys (163) pacientai, kuri virusai buvo jautrs agenerase, maziausiai vienam pi ir vienam nrti.
one hundred and sixty-three (163) patients with virus sensitive to agenerase, at least one other pi, and at least one nrti were included in pro30017 substudy a.

klinikini tyrim metu sesiasdesimt septyniems procentams (67%) pacient pasireisk bent viena su infuzija susijusi reakcija (zr.4. 8 skyri) .
in clinical trials, sixty seven percent (67%) of the patients experienced at least one infusion-associated reaction (see section 4.8) .

klinikinio tyrimo (aspire) metu tiriant pacientus, sergancius reumatoidiniu artritu, sesiasdesimt sesiems procentams pacient (686 is 1040) buvo skiriama maziausiai viena sutrumpinta iki 90 minuci ar trumpesn infuzija, o 44% pacient (454 is 1040) buvo skiriama maziausiai viena sutrumpinta iki 60 minuci ar trumpesn infuzija.
in a clinical study of patients with rheumatoid arthritis (aspire) , sixty six percent of the patients (686 out of 1040) received at least one shortened infusion of 90 minutes or less and 44% of the patients (454 out of 1040) received at least one shortened infusion of 60 minutes or less.